← Back to Search

Observational (long-term follow-up) for Leukemia

N/A
Recruiting
Led By Smita Bhatia
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 years
Awards & highlights

Summary

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Eligible Conditions
  • Leukemia
  • Solid Tumors
  • Bone Marrow Transplant Recipient

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 20 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Collection of protocol-specific outcome data
Percentage of located patients enrolled

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (long-term follow-up)Experimental Treatment2 Interventions
Within 3 months of enrollment on ALTE05N1, patients receive a packet introducing the Long-Term Follow-Up Center (LTFC). Patients are asked to complete a patient response form, verify information provided in packet, and update contact and health status information. The Health Status Update Form is a brief document including questions about current health status, disease status, and cancer therapy received since the last mailing. Patients may respond by use of postage prepaid envelopes, secure online form, or 24-hour toll-free telephone number. After initial contact, the LTFC will contact the patient annually

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,841 Previous Clinical Trials
40,997,815 Total Patients Enrolled
1,526 Trials studying Leukemia
380,327 Patients Enrolled for Leukemia
Children's Oncology GroupLead Sponsor
457 Previous Clinical Trials
234,830 Total Patients Enrolled
171 Trials studying Leukemia
98,242 Patients Enrolled for Leukemia
Smita BhatiaPrincipal InvestigatorChildren's Oncology Group
3 Previous Clinical Trials
5,175 Total Patients Enrolled
2 Trials studying Leukemia
1,290 Patients Enrolled for Leukemia
~3333 spots leftby Jan 2100
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top